Otsuka (OTCMKTS:OTSKY) Stock Crosses Above Fifty Day Moving Average – Here’s Why

Otsuka Holdings Co., Ltd. – Unsponsored ADR (OTCMKTS:OTSKY) passed above its 50-day moving average during trading on Friday . The stock has a 50-day moving average of $34.11 and traded as high as $35.48. Otsuka shares last traded at $35.37, with a volume of 28,470 shares changing hands.

Analysts Set New Price Targets

OTSKY has been the topic of a number of analyst reports. The Goldman Sachs Group lowered shares of Otsuka from a “strong-buy” rating to a “strong sell” rating in a research note on Friday, February 27th. Morgan Stanley upgraded shares of Otsuka to an “overweight” rating in a research note on Friday, January 23rd. UBS Group upgraded shares of Otsuka to a “hold” rating in a research note on Tuesday, January 27th. Finally, Zacks Research upgraded shares of Otsuka from a “strong sell” rating to a “hold” rating in a research note on Tuesday, March 31st. One analyst has rated the stock with a Buy rating, two have issued a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat, the stock has a consensus rating of “Hold”.

Otsuka Price Performance

The company has a quick ratio of 1.67, a current ratio of 2.17 and a debt-to-equity ratio of 0.05. The business’s 50 day moving average price is $34.11 and its 200-day moving average price is $30.89. The company has a market cap of $37.99 billion and a PE ratio of 14.92.

Otsuka (OTCMKTS:OTSKY) last issued its quarterly earnings results on Tuesday, April 28th. The company reported $0.59 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.43 by $0.16. The business had revenue of $3.96 billion during the quarter, compared to analyst estimates of $3.78 billion. Otsuka had a net margin of 15.01% and a return on equity of 12.33%. Otsuka has set its FY 2026 guidance at 1.610-1.610 EPS. As a group, analysts forecast that Otsuka Holdings Co., Ltd. – Unsponsored ADR will post 1.86 earnings per share for the current year.

About Otsuka

Otsuka Pharmaceutical Co, Ltd., trading in the U.S. under the ticker OTCMKTS:OTSKY, is a global healthcare company headquartered in Tokyo, Japan. The firm’s core activities span the development, manufacturing and marketing of prescription pharmaceuticals, consumer healthcare products and nutraceuticals. Otsuka focuses its research on areas such as neuroscience, cardiovascular and renal therapies, and oncology, aiming to bring innovative treatments to patients worldwide.

Founded in 1964 by Busaburo Otsuka as a subsidiary of the Otsuka Group, the company has grown into a diversified healthcare enterprise over more than five decades.